Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

SHA:688739 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,670	1,676	1,750	1,815	2,088	1,996
Revenue Growth (YoY)	-5.19%	-4.22%	-3.58%	-13.08%	4.63%	19.00%
Cost of Revenue	343.31	319.24	342.56	243.28	220.37	279.08
Gross Profit	1,327	1,357	1,408	1,572	1,868	1,716
Selling, General & Admin	653.94	659.02	648.29	588.41	603.58	507.42
Research & Development	274.81	281.94	219.96	210.89	236.82	222.37
Other Operating Expenses	23.91	22.63	21.86	22.1	20.82	17.05
Operating Expenses	967.53	972.25	902.89	836.49	877.65	740.58
Operating Income	359.08	384.75	504.66	735.23	990.02	975.92
Interest Expense	-1.52	-1.58	-1.42	-1.32	-1.54	-
Interest & Investment Income	68.07	70.5	96.81	128.3	45.81	42.58
Currency Exchange Gain (Loss)	0.84	0.84	2.47	2.5	-0.48	-1.04
Other Non Operating Income (Expenses)	-0.2	-0.28	-0.82	-0.47	-0.42	-0.64
EBT Excluding Unusual Items	426.27	454.22	601.71	864.25	1,033	1,017
Gain (Loss) on Sale of Investments	-77.95	-75.57	-45.29	-43.63	-25.53	51.19
Gain (Loss) on Sale of Assets	-1.76	-1.72	1.61	-0.79	-0.69	-23.66
Asset Writedown	2.57	-	-	-	-	-
Other Unusual Items	26.08	26.08	18.36	18.25	23.81	18.57
Pretax Income	375.21	403.02	576.38	838.07	1,031	1,063
Income Tax Expense	41.63	60.2	110.46	124.05	138.49	144.72
Net Income	333.58	342.82	465.92	714.02	892.49	918.19
Net Income to Common	333.58	342.82	465.92	714.02	892.49	918.19
Net Income Growth	-20.64%	-26.42%	-34.75%	-20.00%	-2.80%	31.48%
Shares Outstanding (Basic)	412	413	416	418	381	375
Shares Outstanding (Diluted)	412	413	416	418	381	375
Shares Change (YoY)	-0.93%	-0.71%	-0.37%	9.48%	1.77%	-0.18%
EPS (Basic)	0.81	0.83	1.12	1.71	2.34	2.45
EPS (Diluted)	0.81	0.83	1.12	1.71	2.34	2.45
EPS Growth	-19.90%	-25.89%	-34.50%	-26.92%	-4.49%	31.72%
Free Cash Flow	160.26	138.48	125.02	34.89	-1.97	671.35
Free Cash Flow Per Share	0.39	0.34	0.30	0.08	-0.01	1.79
Dividend Per Share	0.800	0.800	0.800	1.000	1.000	-
Dividend Growth	-	-	-20.00%	-	-	-
Gross Margin	79.44%	80.95%	80.43%	86.60%	89.45%	86.02%
Operating Margin	21.50%	22.95%	28.84%	40.51%	47.41%	48.90%
Profit Margin	19.98%	20.45%	26.62%	39.34%	42.74%	46.01%
Free Cash Flow Margin	9.60%	8.26%	7.14%	1.92%	-0.09%	33.64%
EBITDA	535.31	549.77	624.89	851.42	1,101	1,041
EBITDA Margin	32.06%	32.80%	35.71%	46.91%	52.73%	52.15%
D&A For EBITDA	176.22	165.02	120.24	116.19	111.07	64.84
EBIT	359.08	384.75	504.66	735.23	990.02	975.92
EBIT Margin	21.50%	22.95%	28.84%	40.51%	47.41%	48.90%
Effective Tax Rate	11.10%	14.94%	19.16%	14.80%	13.43%	13.62%
Revenue as Reported	1,670	1,676	1,750	1,815	2,088	1,996

Source: S&P Global Market Intelligence. Standard template. Financial Sources.